Mutation detail:
Mutation site | N265S |
Virus | Influenzavirus A H1N1 |
Mutation level ![]() |
Amino acid Level |
Gene/protein/region type | PB2 |
Gene ID | 23308131 |
Country | - |
Mutation type ![]() |
nonsynonymous mutation |
Genotype/subtype/clade | - |
Sample ![]() |
cell line |
Variants | - |
Viral reference sequence | FJ966079.1 |
Drug/antibody/vaccine | - |
Transmissibility ![]() |
- |
Transmission mechanism | - |
Pathogenicity ![]() |
- |
Pathogenicity mechanism | - |
Immune escape mutation | - |
Immune escape mechanism | - |
RT-PCR primers probes | - |
Protein detail:
Protein name | Polymerase PB2 |
Uniprot protein ID | C3W5X5 |
Protein length | 759 amino acids |
Protein description | PB2 plays an essential role in transcription initiation and cap-stealing mechanism, in which cellular capped pre-mRNAs are used to generate primers for viral transcription. Recognizes and binds the 7-methylguanosine-containing cap of the target pre-RNA which is subsequently cleaved after 10-13 nucleotides by the viral protein PA. Plays a role in the initiation of the viral genome replication and modulates the activity of the ribonucleoprotein (RNP) complex. |
Literature information:
Pubmed ID | 25122786 |
Clinical information | No |
Disease | - |
Published year | 2014 |
Journal | JOURNAL OF VIROLOGY |
Title | The Temperature-Sensitive and Attenuation Phenotypes Conferred by Mutations in the Influenza Virus PB2, PB1, and NP Genes Are Influenced by the Species of Origin of the PB2 Gene in Reassortant Viruses Derived from Influenza A/California/07/2009 and A/WSN/ |
Author | Andrew J. Broadbent,Celia P. Santos,Rachel A. Godbout,Kanta Subbarao |
Evidence | The following mutations were made in the WSN, CA07, and VN04 plasmids: PB1-K391E, -E581G, and -A661T and PB2-N265S. In addition, a D34G mutation was made in the WSN NP plasmid and an S34G mutation was made in the VN04 NP plasmid. The CA07 NP plasmid already contained a glycine at amino acid position 34, so it was not necessary to mutate the plasmid. |